Genew Technologies Co. Ltd. is a global system provider for end-to-end communication solutions and telecom infrastructures, established in 2005 and quoted in the Shanghai stock market (ticker: 688418.SS).
Genew Technologies as a high-tech company, relies on its own resources of independent research and innovation as its major strength. It is headquartered in Shenzhen , China and it has branch offices in the Philippines , India , Japan,
Spain, UAE and Bangladesh.At present, Genew has become a leading company providing solutions and services to telecom operators , service providers, industrial and governmental organizations, serving more than 60M global users,possessing about 1500 employees .
After years of research and development, Genew Technologies' solutions cover data and voice products within the core , access, transport and wireless communication infrastructures, highlighting some of its product lines such as Core (IMS, EPC, RCS), Broadband Access (MSAN, OLT, ONT, 4G/5G CPE, L2/L3 Switches), Transport (C/DWDM, DCI, MSTP), Wireless (Wi-Fi). Genew has also a broad portfolio of vertical solutions including but not only, Smart Mining, Smart City and Emergency Communication Command Center.
Genew latest launch related with core and wireless technologies is 5G end-to-end solution, completely develop in home at our R&D centers covering 5G Core, 5G O-RAN, 5G front haul, 5G clock/ synchronization and others. Genew is also launching a new family of OLTs incorporating latest innovations in the industry as software virtualization, disaggregation, high-capacity uplinks (100G) and combo interfaces (GPON/XGPON/XGSPON).
5/6th Floor, Richinfo Innovation Center 3176 South Keyuan Road, South Hi-Tech Park Nanshan District, Shenzhen, 518057 P. R. China., Shenzhen,guangdong 518057,china
Evidence for in vivo resistance against allopurinol in a dog infected with Leishmania infantum by reduction in copy numbers of the S-adenosylmethionine synthetase (METK) gene Parasites & Vectors
Association of ERBB2 Copy Number and Gene Coalterations With Trastuzumab Efficacy and Resistance in Human Epidermal Growth Factor Receptor 2–Positive Esophagogastric and Gastric Cancer | JCO Precision Oncology ASCO Publications
Coexisting cancer stem cells with heterogeneous gene amplifications, transcriptional profiles, and malignancy are isolated from single glioblastomas ScienceDirect.com
Co-amplification of CBX3 with EGFR or RAC1 in human cancers corroborated by a conserved genetic interaction among the genes | Cell Death Discovery Nature
Genomic characterization of Leishmania V. braziliensis associated with antimony therapeutic failure and variable in vitro tolerance to amphotericin B Nature
The FAM3C locus that encodes interleukin-like EMT inducer (ILEI) is frequently co-amplified in MET-amplified cancers and contributes to invasiveness Journal of Experimental & Clinical Cancer Research
Integrative Analysis of Methylation and Copy Number Variations of Prostate Adenocarcinoma Based on Weighted Gene Co-expression Network Analysis Frontiers
Mosaicism of XX and XXY cells accounts for high copy number of Toll like Receptor 7 and 8 genes in peripheral blood of men with Rheumatoid Arthritis Nature
Sign up for a free account. No credit card required. Up to 10 free credits.
Search the #1 Contact Database
Get contact details of over 750M+ profiles across 60M companies – all with industry-leading accuracy. Sales Navigator and Recruiter users, try out our Email Finder Extension.
Use our AI-Powered Email Finder
Find business and personal emails and mobile phone numbers with exclusive coverage across niche job titles, industries, and more for unparalleled targeting. Also available via our Contact Data API.